Search

everythinglearnresearchcommunity

for

Search:↓

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

A woman with Budd-Chiari syndrome improved after treatment and needs a liver transplant, highlighting the importance of considering non-criteria antiphospholipid syndrome in similar cases.

Hsa-miR-193a-5p is important in alopecia areata by promoting inflammation and involving specific genes in hair and immune function.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Both treatments for alopecia areata are equally effective and safe.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

Alopecia areata in elderly people is usually mild and responds well to treatment.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Avacopan may cause unexpected side effects, so early monitoring is important.

Dental care may help improve hair loss in alopecia patients.

Wiesbaden 30CH is more effective than supportive haircare for improving telogen effluvium.

Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

Sreeparna Majumder showed incredible resilience and determination despite battling cancer.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Dermoscopy is a useful tool for diagnosing and managing alopecia areata.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

New therapies are being developed that target integrin pathways to treat various diseases.

Patients with alopecia areata have lower zinc levels, and zinc supplements might help.

Gray hair may be caused by lower antioxidant activity in hair cells.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Some diets and supplements might help with skin disorders, but their effectiveness varies and more research is needed.

Mesenchymal stem cells and their vesicles may effectively treat skin diseases, but more research is needed.

Too much epidermal growth factor can cause hair loss.